AKUS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AKUS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Akouos's cash to debt ratio for the quarter that ended in Sep. 2022 was 4.79.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Akouos could pay off its debt using the cash in hand for the quarter that ended in Sep. 2022.
The historical rank and industry rank for Akouos's Cash-to-Debt or its related term are showing as below:
During the past 4 years, Akouos's highest Cash to Debt Ratio was No Debt. The lowest was 1.82. And the median was 8.02.
The historical data trend for Akouos's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Akouos Annual Data | |||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | |||||
Cash-to-Debt | No Debt | 1.82 | 23.44 | 8.02 |
Akouos Quarterly Data | ||||||||||||||||
Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | |
Cash-to-Debt | Get a 7-Day Free Trial | 8.68 | 8.02 | 7.18 | 5.89 | 4.79 |
For the Biotechnology subindustry, Akouos's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Akouos's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Akouos's Cash-to-Debt falls into.
This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.
Akouos's Cash to Debt Ratio for the fiscal year that ended in Dec. 2021 is calculated as:
Cash to Debt Ratio | = | Cash, Cash Equivalents, Marketable Securities | / | Total Debt | ||
= | Cash, Cash Equivalents, Marketable Securities | / | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | |
= | 232.452 | / | (0.671 | + | 28.304) | |
= | 8.02 |
Akouos's Cash to Debt Ratio for the quarter that ended in Sep. 2022 is calculated as:
Cash to Debt Ratio | = | Cash, Cash Equivalents, Marketable Securities | / | Total Debt | ||
= | Cash, Cash Equivalents, Marketable Securities | / | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | |
= | 169.328 | / | (0.785 | + | 34.584) | |
= | 4.79 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akouos (NAS:AKUS) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Thank you for viewing the detailed overview of Akouos's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.
Kearny Acquisition Corp | 10 percent owner | LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285 |
Lilly Eli & Co | 10 percent owner | LILLY CORPORATE CENTER, DROP CODE 1094, INDIANAPOLIS IN 46285 |
Jennifer Anne Wellman | officer: Chief Operating Officer | C/O AKOUOS, INC., 645 SUMMER STREET, SUITE 200, BOSTON MA 02210 |
Sachiyo Minegishi | officer: Chief Financial Officer | C/O AKOUOS, INC., 645 SUMMER STREET, SUITE 200, BOSTON MA 02210 |
5am Ventures V, L.p. | 10 percent owner | 2200 SAND HILL ROAD, SUITE 110, MENLO PARK CA 94025 |
Kush Parmar | director, 10 percent owner | C/O 5AM VENTURES, 501 2ND STREET, SUITE 350, SAN FRANCISCO CA 94107 |
Carmen Chang | 10 percent owner | 2855 SAND HILL ROAD, MENLO PARK CA 94025 |
Maha Katabi | 10 percent owner | SOFINNOVA INVESTMENTS, 3000 SAND HILL ROAD, 4-250, MENLO PARK CA 94025 |
Sofinnova Venture Partners X, L.p. | 10 percent owner | 3000 SAND HILL ROAD, 4-250, MENLO PARK CA 94025 |
Pivotal Bioventure Partners Fund I G.p., L.p. | 10 percent owner | 501 SECOND STREET, SUITE 200, SAN FRANCISCO CA 94107 |
New Enterprise Associates 16, L.p. | 10 percent owner | 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093 |
Paul Edward Walker | 10 percent owner | 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093 |
Ecor1 Capital, Llc | 10 percent owner | 357 TEHAMA STREET #3, SAN FRANCISCO CA 94103 |
Cormorant Asset Management, Lp | 10 percent owner | 200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116 |
Heather Preston | director, 10 percent owner | C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, FORT WORTH TX 76102 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 06-11-2022
By PRNewswire PRNewswire • 11-03-2022
By PRNewswire PRNewswire • 10-25-2022
By PRNewswire PRNewswire • 10-21-2022
By PRNewswire PRNewswire • 10-18-2022
By GuruFocusNews GuruFocusNews • 07-08-2022
By GuruFocusNews GuruFocusNews • 05-12-2022
By GuruFocusNews GuruFocusNews • 05-22-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.